An Interventional, Placebo-Controlled, Randomized, Double-blinded Dose Comparison, Phase I Study to Determine the Safety and; Efficacy of a New Gel Formulation of Esmolol Hydrochloride (Galnobax) for the Treatment of Diabetic Foot Ulcer (DFU)

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 22 May 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Esmolol (Primary)
Indications Diabetic foot ulcer
Focus Adverse reactions; Therapeutic Use
Sponsors NovaLead Pharma Pvt. Ltd

Most Recent Events

27 Jan 2016 Status changed from active, no longer recruiting to completed, as reported on the company pipeline.
26 Sep 2013 New source identified and integrated (Clinical Trials Registry - India: CTRI2013-07-003838).
05 May 2010 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight